Related Experiment Videos
[Pulmonary complications in haploidentical bone marrow transplantation]
Heng-Xiang Wang1, Shu-Quan Ji, Ling Zhu
1Department of Hematology, General Hospital of Air Force, PLA, Beijing 100036, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|May 26, 2004
Summary
Pulmonary complications are common after haploidentical bone marrow transplantation. Fungal pneumonia, occurring 2-3 months post-transplant, is a primary concern requiring intensive management for better patient outcomes.
Area of Science:
- Hematology
- Pulmonology
- Infectious Diseases
Context:
- Haploidentical bone marrow transplantation is a life-saving procedure for various hematologic malignancies.
- Pulmonary complications represent a significant cause of morbidity and mortality following transplantation.
- Understanding the temporal patterns and etiologies of these complications is crucial for timely intervention.
Purpose:
- To investigate the occurrence patterns, including onset time and etiology, of pulmonary complications in patients undergoing haploidentical bone marrow transplantation.
- To analyze the management strategies and outcomes associated with different types of pulmonary complications.
- To identify key pathogens and their timing relative to transplantation.
Summary:
- Pulmonary complications occurred in 18 of 70 patients (25.7%) post-haploidentical bone marrow transplantation.
- Pneumonia was the most frequent complication, caused by bacteria (7 cases), fungi (5 cases), and cytomegalovirus (CMV, 4 cases).
- Fungal and CMV pneumonia predominantly occurred 2-3 months post-transplant, while bacterial pneumonia appeared 3-12 months later. Bronchiolitis obliterans organizing pneumonia (BOOP) and idiopathic pneumonia syndrome were diagnosed later. Eight patients died, with fungal pneumonia identified as a major contributor.
Impact:
- This study highlights the high incidence of pulmonary complications after haploidentical bone marrow transplantation.
- It emphasizes the critical role of fungal pneumonia as a leading cause of mortality, necessitating focused diagnostic and therapeutic approaches.
- Findings can inform clinical practice for improved surveillance and management protocols to reduce post-transplant pulmonary complications.